3S Corporation is one of India’s leading stockist, exporter & wholesaler for Anti-cancer drug & Oncology medicines. We even supply & export Sex Enhancement Drugs, Cardiac & Anti Diabetic Medicines. We are a registered wholesaler & exporter for pharmaceutical products licensed by our FDA and Drug Controller in India. Our license number are 20-B/MZ6-23015 & 21-B/ MZ6-23016.
Andheri East, Mumbai - 400099,
All the pharmaceutical products we offer are prescription drugs and should be used/taken under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug. We are not an online pharmacy . We do not recommend any drug or give medical advice. We only express opinions and provide information. Whether a medication is right for you is a decision between you and the prescribing doctor. Kindly seek medical advice from a registered doctor 0r hospital/Institution before taking any of these medicines.
Lyophilized Carboplatin injection 150mg & 450 mg is used in initial treatment of advanced ovarian carcinoma in combination with other chemotherapy agents and secondary treatment for palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy.
There are many generic manufacturers in India who manufacture Lyophilized Carboplatin injection 150mg & 450 mg including United Biotech Ltd etc.
3s corporation is Supplier,Exporter ,Wholesaler for Lyophilized Carboplatin injection 150mg & 450 mg in India.
We even offer contract manufacturing services from WHO GMP approved factories.
Reconstituted solution of Lyophilized Carboplatin injection is stable for 8 h at controlled room temperature (77°F). Reconstituted solution does not contain a preservative and any unused solution must be discarded 8 h after reconstitution. Do not save any unused solution for future use. Carboplatin aqueous solution multidose vials are stable at room temperature (77°F) for up to 14 days following initial needle entry.
CV events (11%); fatal CV events including cardiac failure, embolism, cerebrovascular accidents (less than 1%); hypertension .
Asthenia (23%); peripheral neuropathies including mild paresthesias (6%); central neurotoxicity (5%); ototoxicity (1%); malaise .
Reversible vision loss.
Sodium loss (47%); magnesium loss (43%); calcium loss (31%); potassium loss (28%).
Nausea and vomiting (92%); vomiting (81%); other GI side effects (21%); anorexia.
Elevated BUN (22%); elevated serum creatinine (10%).